Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV-1 reverse transcriptase inhibitors: current issues and future perspectives.

G A Locatelli1, R Cancio, S Spadari

  • 1DNA Enzymology & Molecular Virology, Istituto di Genetica Molecolare IGM-CNR, via Abbiategrasso 207, Pavia, Italy.

Current Drug Metabolism
|August 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular docking, design, synthesis and biological evaluation of novel 2,3-aryl-thiazolidin-4-ones as potent NNRTIs.

SAR and QSAR in environmental research·2019
Same author

The major DNA polymerase in cultured plant cells: Partial purification and correlation with cell multiplication.

Planta·2013
Same author

Inactivation of aphidicolin by plant cells.

Plant cell reports·2013
Same author

RFLP-based genetic relationships of Einkorn wheats.

TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·2013
Same author

What makes y family pols potential candidates for molecular targeted therapies and novel biotechnological applications.

Current molecular medicine·2013
Same author

Tyrosine kinases as essential cellular cofactors and potential therapeutic targets for human immunodeficiency virus infection.

Cellular and molecular biology (Noisy-le-Grand, France)·2013
Same journal

Corrigendum to: Nanocochleates in Clinical Trials: A Review of Current Status, Challenges, and Future Directions.

Current drug metabolism·2026
Same journal

Shenfu Decoction Extends Survival Time of Seawater-Induced Hypothermia in Rats: The Role of Metabolomics and Gut Microbiota.

Current drug metabolism·2026
Same journal

Nucleic Acid Nanomaterials Targeting Autophagy in Bone Regeneration.

Current drug metabolism·2026
Same journal

Nicotinamide N-Methyltransferase (NNMT): A Central Regulator in Hepatocellular Carcinoma Metabolism and Therapeutic Targeting - A Systematic Review.

Current drug metabolism·2026
Same journal

Chlorzoxazone-based One-Sample Method for Estimating In Vivo CYP2E1 Activity in Mice.

Current drug metabolism·2026
Same journal

Unraveling the Gut Microbiota-Mediated Mechanism of Guogong Jiu for Rheumatoid Arthritis Treatment through Network Pharmacology and Metabolomics.

Current drug metabolism·2026
See all related articles

New antiretroviral drugs are crucial for HIV treatment. This review covers advances and future directions in developing novel reverse transcriptase (RT) inhibitors to combat HIV infection effectively.

Area of Science:

  • Virology
  • Pharmacology
  • Infectious Diseases

Background:

  • Antiretroviral drugs have revolutionized HIV treatment.
  • Reverse transcriptase (RT) inhibitors form the core of current HIV combination therapies.
  • Highly active antiretroviral combination chemotherapy (HAART) suppresses viral replication but does not eradicate HIV.

Purpose of the Study:

  • To review recent advancements in the development of novel anti-RT compounds.
  • To explore future directions in designing new HIV therapies.
  • To address challenges in current HIV treatment regimens.

Main Methods:

  • Literature review of recent scientific publications.
  • Analysis of current trends in antiretroviral drug development.
  • Synthesis of information on RT inhibitor research.

Related Experiment Videos

Main Results:

  • RT inhibitors are central to effective HIV management.
  • HAART significantly suppresses viral load and delays resistance.
  • Challenges include drug toxicity and emerging drug resistance.

Conclusions:

  • Continued development of novel anti-RT compounds is essential for improving HIV treatment.
  • Future research should focus on overcoming drug resistance and toxicity.
  • Novel therapies are needed to achieve a definitive cure for HIV.